Evaluation of prescribing patterns of sodium valproate in neurological disease patients: a quasi-experimental pretest–posttest design study

Abstract Background The well-known anti-seizure medication, sodium valproate, is used to treat epilepsy, bipolar disorder, and other mental health conditions. Objective This study aimed to determine how pharmacist counseling intervention affected the prescribing patterns and usage of sodium valproat...

Full description

Saved in:
Bibliographic Details
Main Authors: Rehab H. Werida, Salima El-Sherif, Rania Shoshan, Naglaa F. Khedr
Format: Article
Language:English
Published: BMC 2025-03-01
Series:BMC Health Services Research
Subjects:
Online Access:https://doi.org/10.1186/s12913-025-12483-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849391053286670336
author Rehab H. Werida
Salima El-Sherif
Rania Shoshan
Naglaa F. Khedr
author_facet Rehab H. Werida
Salima El-Sherif
Rania Shoshan
Naglaa F. Khedr
author_sort Rehab H. Werida
collection DOAJ
description Abstract Background The well-known anti-seizure medication, sodium valproate, is used to treat epilepsy, bipolar disorder, and other mental health conditions. Objective This study aimed to determine how pharmacist counseling intervention affected the prescribing patterns and usage of sodium valproate in patients with neurological diseases. Methods Patient prescriptions were analyzed in a quasi-experimental pretest–posttest design research, at baseline and after three months of pharmacy educational intervention. Medical history, drug-drug interactions, antipsychotic combinations, medication errors, and dosages were among the information gathered. Results The reviewed prescriptions observed trend towards antipsychotic combination, 15 (2.5%) prescriptions had five medications, while 18 (3%) contained four, 169 (28.2%) containing three, 329 (54.8%) containing two, and 69 (11.5%) containing one, antipsychotic. Of the reviewed prescriptions, 6% had possible drug-drug interactions. However, following a 3-month pharmacy educational intervention, the tendency toward antipsychotic combination decreased significantly to 262 (52%) with prescriptions for 2 antipsychotics and 163 (32.3%) with 3 antipsychotics. Likewise, the decreases in medication errors related to frequency and dosage were 8 (1.6%) vs. 29 (4.8%) and 6 (1.2%) vs. 35 (5.8%), compared to baseline respectively. Additionally, medication adherence was raised significantly (p < 0.000) from 50 (8.3%) to 338 (67.1%) after the intervention. Conclusion More precise regulations should be placed on sodium valproate prescription patterns and usage, throughout implemented pharmacist initiative in patients counselling, provision of health education and therapeutic monitoring to improve health-related quality of life. Trial registration This study was registered on clinicaltrial.gov with an identification code NCT05830981. https://classic.clinicaltrials.gov/ct2/show/NCT05830981 (First Posted: April 26, 2023). Graphical abstract
format Article
id doaj-art-2c3013a76efa4fbd9e107582ffd07681
institution Kabale University
issn 1472-6963
language English
publishDate 2025-03-01
publisher BMC
record_format Article
series BMC Health Services Research
spelling doaj-art-2c3013a76efa4fbd9e107582ffd076812025-08-20T03:41:12ZengBMCBMC Health Services Research1472-69632025-03-0125111210.1186/s12913-025-12483-5Evaluation of prescribing patterns of sodium valproate in neurological disease patients: a quasi-experimental pretest–posttest design studyRehab H. Werida0Salima El-Sherif1Rania Shoshan2Naglaa F. Khedr3Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Damanhour UniversityFaculty of Pharmacy, Mansoura UniversityNeurology Department, Mansoura University HospitalBiochemistry Department, Faculty of Pharmacy, Tanta UniversityAbstract Background The well-known anti-seizure medication, sodium valproate, is used to treat epilepsy, bipolar disorder, and other mental health conditions. Objective This study aimed to determine how pharmacist counseling intervention affected the prescribing patterns and usage of sodium valproate in patients with neurological diseases. Methods Patient prescriptions were analyzed in a quasi-experimental pretest–posttest design research, at baseline and after three months of pharmacy educational intervention. Medical history, drug-drug interactions, antipsychotic combinations, medication errors, and dosages were among the information gathered. Results The reviewed prescriptions observed trend towards antipsychotic combination, 15 (2.5%) prescriptions had five medications, while 18 (3%) contained four, 169 (28.2%) containing three, 329 (54.8%) containing two, and 69 (11.5%) containing one, antipsychotic. Of the reviewed prescriptions, 6% had possible drug-drug interactions. However, following a 3-month pharmacy educational intervention, the tendency toward antipsychotic combination decreased significantly to 262 (52%) with prescriptions for 2 antipsychotics and 163 (32.3%) with 3 antipsychotics. Likewise, the decreases in medication errors related to frequency and dosage were 8 (1.6%) vs. 29 (4.8%) and 6 (1.2%) vs. 35 (5.8%), compared to baseline respectively. Additionally, medication adherence was raised significantly (p < 0.000) from 50 (8.3%) to 338 (67.1%) after the intervention. Conclusion More precise regulations should be placed on sodium valproate prescription patterns and usage, throughout implemented pharmacist initiative in patients counselling, provision of health education and therapeutic monitoring to improve health-related quality of life. Trial registration This study was registered on clinicaltrial.gov with an identification code NCT05830981. https://classic.clinicaltrials.gov/ct2/show/NCT05830981 (First Posted: April 26, 2023). Graphical abstracthttps://doi.org/10.1186/s12913-025-12483-5Prescribing PatternPharmacy educationSodium valproateAnti-seizureOutpatientsAdherence
spellingShingle Rehab H. Werida
Salima El-Sherif
Rania Shoshan
Naglaa F. Khedr
Evaluation of prescribing patterns of sodium valproate in neurological disease patients: a quasi-experimental pretest–posttest design study
BMC Health Services Research
Prescribing Pattern
Pharmacy education
Sodium valproate
Anti-seizure
Outpatients
Adherence
title Evaluation of prescribing patterns of sodium valproate in neurological disease patients: a quasi-experimental pretest–posttest design study
title_full Evaluation of prescribing patterns of sodium valproate in neurological disease patients: a quasi-experimental pretest–posttest design study
title_fullStr Evaluation of prescribing patterns of sodium valproate in neurological disease patients: a quasi-experimental pretest–posttest design study
title_full_unstemmed Evaluation of prescribing patterns of sodium valproate in neurological disease patients: a quasi-experimental pretest–posttest design study
title_short Evaluation of prescribing patterns of sodium valproate in neurological disease patients: a quasi-experimental pretest–posttest design study
title_sort evaluation of prescribing patterns of sodium valproate in neurological disease patients a quasi experimental pretest posttest design study
topic Prescribing Pattern
Pharmacy education
Sodium valproate
Anti-seizure
Outpatients
Adherence
url https://doi.org/10.1186/s12913-025-12483-5
work_keys_str_mv AT rehabhwerida evaluationofprescribingpatternsofsodiumvalproateinneurologicaldiseasepatientsaquasiexperimentalpretestposttestdesignstudy
AT salimaelsherif evaluationofprescribingpatternsofsodiumvalproateinneurologicaldiseasepatientsaquasiexperimentalpretestposttestdesignstudy
AT raniashoshan evaluationofprescribingpatternsofsodiumvalproateinneurologicaldiseasepatientsaquasiexperimentalpretestposttestdesignstudy
AT naglaafkhedr evaluationofprescribingpatternsofsodiumvalproateinneurologicaldiseasepatientsaquasiexperimentalpretestposttestdesignstudy